# MTERF1

## Overview
MTERF1, or mitochondrial transcription termination factor 1, is a gene that encodes a protein involved in the regulation of mitochondrial DNA (mtDNA) transcription and replication. The MTERF1 protein is categorized as a transcription factor and is characterized by its all-alpha helical structure, which facilitates its interaction with DNA. It plays a critical role in terminating transcription downstream of the ribosomal transcription unit, thereby preventing antisense transcription and ensuring the proper coordination of mtDNA replication and transcription (Shi2016Mitochondrial). This function is vital for maintaining mitochondrial genomic stability and efficient gene expression. MTERF1 also acts as a directional contrahelicase, interacting with the mitochondrial helicase TWINKLE to prevent potential clashes between replication and transcription processes (Shi2016Mitochondrial). Mutations in the MTERF1 gene have been associated with various mitochondrial disorders, highlighting its clinical significance (Yakubovskaya2010Helix). Additionally, MTERF1 expression levels have been linked to prognostic outcomes in non-small cell lung cancer, suggesting its potential role as a biomarker (Sun2019Prognostic).

## Structure
The MTERF1 protein is a modular, all-alpha helical protein composed of 19 alpha helices and 7 3_10 helices, organized around a repeated motif known as the mterf motif. This motif consists of two alpha helices followed by a 3_10 helix, repeated throughout the structure (Yakubovskaya2010Helix). The protein's fold is similar to other all-alpha helical regions such as armadillo (ARM), HEAT, and PUM/PUF motifs, which are known for their roles in RNA and DNA binding (Yakubovskaya2010Helix). MTERF1 binds to DNA as a monomer, covering twenty base pairs and causing a slight bend and significant unwinding of the DNA duplex (Yakubovskaya2010Helix).

The protein's structure is characterized by a right-handed superhelical fold that interacts with the major groove of DNA, inducing DNA bending and helix unwinding (Byrnes2016Base). This interaction results in the eversion of three nucleotides, stabilized by stacking interactions with specific residues such as Arg162, Phe243, and Tyr288 (Byrnes2016Base). These interactions are crucial for the base flipping mechanism, which is essential for transcriptional termination (Byrnes2016Base). The modular architecture and hydrophobic interactions within and between motifs suggest rigidity of individual motifs but flexibility between them, contributing to the overall fold's adaptability (Yakubovskaya2010Helix).

## Function
MTERF1 (mitochondrial transcription termination factor 1) is a protein that plays a crucial role in the regulation of mitochondrial DNA (mtDNA) transcription and replication. It binds to specific DNA sequences downstream of the ribosomal transcription unit, effectively terminating transcription and preventing antisense transcription over the ribosomal RNA genes (Shi2016Mitochondrial). This termination function is essential for maintaining the proper coordination of DNA replication and transcription, ensuring genomic stability and efficient gene expression within mitochondria (Shi2016Mitochondrial).

MTERF1 acts as a directional contrahelicase, blocking the unwinding of mtDNA by the mitochondrial helicase TWINKLE, which helps prevent potential clashes between replication and transcription processes (Shi2016Mitochondrial). This blocking effect is dose-dependent and is crucial for maintaining mitochondrial DNA integrity and function (Shi2016Mitochondrial).

In addition to its role in transcription termination, MTERF1 is involved in replication fork pausing, acting as a barrier to replication fork progression. This function ensures the proper coordination between replication and transcription processes in mitochondria, which is vital for cellular energy metabolism and mitochondrial biogenesis (Shi2016Mitochondrial).

## Clinical Significance
Mutations in the MTERF1 gene have been linked to several mitochondrial disorders. Specific mutations, such as G3249A and G3242A, significantly impair MTERF1's ability to terminate transcription, which can lead to mitochondrial dysfunction. The G3249A mutation is associated with a variant of Kearns-Sayre syndrome, a mitochondrial myopathy, while G3242A is linked to an uncharacterized mitochondrial disorder (Yakubovskaya2010Helix). These mutations may interfere with MTERF1 activity at the leu-tRNA site, potentially causing transcriptional deregulation (Yakubovskaya2010Helix).

The A3243G mutation, frequently found in MELAS syndrome patients, slightly reduces MTERF1 binding, although it does not significantly alter transcription levels in vivo. This mutation changes an A:T base pair to a stronger G:C base pair, potentially affecting binding dynamics and contributing to the pathogenic effects observed in MELAS (Chomyn1992MELAS; Yakubovskaya2010Helix).

Alterations in MTERF1 expression levels have also been studied in the context of non-small cell lung cancer (NSCLC). High expression levels of MTERF1 are associated with improved overall survival rates in patients with lung adenocarcinoma, suggesting its potential prognostic value in NSCLC (Sun2019Prognostic).

## Interactions
MTERF1 interacts with mitochondrial DNA to regulate transcription termination by binding to specific sequences. This interaction involves a unique mechanism of helix unwinding and base flipping, which stabilizes MTERF1 on the DNA and prevents its displacement. The protein binds DNA in a distorted conformation, with three nucleotides everted from the double-helix, stabilized by stacking interactions and hydrogen bonds. This conformation is specific to certain DNA sequences, indicating that nucleotide eversion is essential for stable, specific binding (Yakubovskaya2010Helix).

MTERF1's interaction with DNA is initially sequence-independent, followed by sequence recognition that induces a conformational change. This allows MTERF1 to interfere with the transcription elongation machinery, particularly affecting transcription from the light strand promoter (LSP) more than the heavy strand promoter (HSP) (Yakubovskaya2010Helix). The protein's ability to bind DNA of arbitrary sequence with lower affinity suggests that MTERF1 can associate with different regions of the DNA duplex, potentially allowing multiple MTERF1 molecules to bind simultaneously (Yakubovskaya2010Helix).

Mutations in the mitochondrial termination sequence, such as G3249A, can eliminate specific DNA binding, while others like G3242A and A3243G result in decreased termination activity, highlighting the importance of specific interactions for MTERF1's function (Yakubovskaya2010Helix).


## References


[1. (Chomyn1992MELAS) A Chomyn, A Martinuzzi, M Yoneda, A Daga, O Hurko, D Johns, S T Lai, I Nonaka, C Angelini, and G Attardi. Melas mutation in mtdna binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proceedings of the National Academy of Sciences, 89(10):4221–4225, May 1992. URL: http://dx.doi.org/10.1073/pnas.89.10.4221, doi:10.1073/pnas.89.10.4221. This article has 363 citations.](https://doi.org/10.1073/pnas.89.10.4221)

[2. (Yakubovskaya2010Helix) Elena Yakubovskaya, Edison Mejia, James Byrnes, Elena Hambardjieva, and Miguel Garcia-Diaz. Helix unwinding and base flipping enable human mterf1 to terminate mitochondrial transcription. Cell, 141(6):982–993, June 2010. URL: http://dx.doi.org/10.1016/j.cell.2010.05.018, doi:10.1016/j.cell.2010.05.018. This article has 88 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2010.05.018)

[3. (Sun2019Prognostic) Shuangyan Sun, Chunjiao Wu, Changliang Yang, Jian Chen, Xiu Wang, Yingji Nan, Zhicheng Huang, and Lixia Ma. Prognostic roles of mitochondrial transcription termination factors in non‑small cell lung cancer. Oncology Letters, July 2019. URL: http://dx.doi.org/10.3892/ol.2019.10680, doi:10.3892/ol.2019.10680. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.10680)

[4. (Shi2016Mitochondrial) Yonghong Shi, Viktor Posse, Xuefeng Zhu, Anne K. Hyvärinen, Howard T. Jacobs, Maria Falkenberg, and Claes M. Gustafsson. Mitochondrial transcription termination factor 1 directs polar replication fork pausing. Nucleic Acids Research, 44(12):5732–5742, April 2016. URL: http://dx.doi.org/10.1093/nar/gkw302, doi:10.1093/nar/gkw302. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkw302)

[5. (Byrnes2016Base) James Byrnes, Kevin Hauser, Leah Norona, Edison Mejia, Carlos Simmerling, and Miguel Garcia-Diaz. Base flipping by mterf1 can accommodate multiple conformations and occurs in a stepwise fashion. Journal of Molecular Biology, 428(12):2542–2556, June 2016. URL: http://dx.doi.org/10.1016/j.jmb.2015.10.021, doi:10.1016/j.jmb.2015.10.021. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2015.10.021)